MedTrace Logo

NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema

NCT00143793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-08-27

No results posted yet for this study

Summary

The objectives of this study are to:

* Evaluate the sensitivity and specificity of NT-proBNP (N-terminal prohormone brain natriuretic peptide) and new biomarker measurements for the diagnosis of heart failure in patients with acute dyspnea and/or edema.
* Determine the exact biomarker cut-off point(s) for the differentiation of healthy persons, patients with heart failure and patients with dyspnea of other origin.
* Evaluate treatment costs in patients with dyspnea under special consideration of NT-proBNP measurement.

Conditions

Sponsors & Collaborators

  • Universitätsmedizin Mannheim

    lead OTHER

Principal Investigators

  • Martina Brueckmann, MD · First Department of Medicine, University Medical Centre Mannheim

  • Martin Borggrefe, MD · First Department of Medicine, University Medical Centre Mannheim

  • Michael Neumaier, MD · Institute of Clinical Chemistry, University Medical Centre Mannheim

  • Parviz Ahmad-Nejad, MD · Institute of Clinical Chemistry, University Medical Centre Mannheim

  • Michael Behnes, MD · First Department of Medicine, University Medical Centre Mannheim

  • Ursula Hoffmann, MD · First Department of Medicine, University Medical Centre Mannheim

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00143793 on ClinicalTrials.gov